(ADMS)
Day Range- - -52 Wk Range- - -Open / Close- / -Float / Outstanding- / -
Vol / Avg.- / -Mkt Cap-P/E-50d Avg. Price-
Div / Yield-Payout Ratio-Total Float-EPS-0.43

Stock (ADMS), Quotes and News Summary

ADMS

Day Range- - -52 Wk Range- - -Open / Close- / -Float / Outstanding- / -
Vol / Avg.- / -Mkt Cap-P/E-50d Avg. Price-
Div / Yield-Payout Ratio-Total Float-EPS-0.43
Adamas Pharmaceuticals Inc discovers, develops, and sells therapies for chronic neurologic disorders. The company's approved/commercial product is GOCOVRI, an amantadine therapy for the treatment of levodopa-induced dyskinesia in patients with Parkinson's disease. It operates in one reportable segment: the development and commercialization of therapeutics targeting chronic disorders of the central nervous system. The company generates its revenues primarily from the United States.

Earnings

see more
Q3 2022Est.ActualSurprise
EPS
(EXPECTED)2022-11-09
REV
Q3 2021Est.ActualSurprise
EPS-0.430
REV25.896M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target